ResMed Reaches Analyst Target Price
23/7 14:26
In recent trading, shares of ResMed Inc. (Symbol: RMD) have crossed above the average analyst 12-month target price of $266.25, changing hands for $267.40/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati...